9 investment trends driving vascular technology innovation in 2026
Venture capital and public healthcare funds are pouring into the bioresorbable scaffold sector at an unprecedented rate in 2026. The focus of this financial influx is the "de-risking" of long-term implants. Investors are increasingly looking for companies that offer full-stack solutions—combining drug-eluting hardware, AI diagnostic software, and post-operative monitoring—to provide...
0 Комментарии 0 Поделились 61 Просмотры 0 предпросмотр
Lifesone https://lifesone.com